STEMI time delays should not be used as the sole surrogate marker for quality of care, as clinical outcomes depend on multiple complex factors including patient baseline risk and appropriate diagnosis.
Answers are grounded in this paper and cite their sources.
STEMI pathways warrant attention to non-time factors; leaves open which issues most affect outcomes.
STEMI time delays have been introduced as a performance indicator or marker of quality of care. As they are only one part of a very complex medical process, one should be aware of concomitant issues that may be overlooked or even be more important with regard to clinical outcome of STEMI patients. In this overview we try to summarise the most important ones.
No takes yet. Share an insight, caveat, or question.
Boer et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: